{'fraction_non_alphanumeric': 0.024886877828054297, 'fraction_numerical': 0.003393665158371041, 'mean_word_length': 5.061643835616438, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Session 4C: Medication Use

person with dementia, their main carer, the prescriber of a medicine for dementia and a dementia-related health care professional (HCP) if appropriate. Perceptions of medicines for dementia were to be contrasted with views from the prescriber and other dementia-related HCPs as appropriate. Patient and carer participants were interviewed up to four times over a 13-month period in their own home. HCPs and prescribers were interviewed on a single occasion in their workplace. All interviews were transcribed verbatim, and identifiable descriptors were removed. Interpretative phenomenological analysis (IPA) was used to analyse interview data. IPA was chosen because it enables the researcher to explore the way in which participants make sense of a life experience (i.e. the phenomena of taking a medicine for dementia or of caring for someone who does).